$1.11
0.00 (-0.03%)
StemCells, Inc. (STEM)
CAPS Rating:
A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.
Fool.com
The World's Greatest Investing Community
RSS Headlines
Fool UK
